证券代码：688551 证券简称：科威尔 公告编号：2026-006 科威尔技术股份有限公司 关于董事减持计划时间届满暨减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 董事持有股份的基本情况 本次减持计划实施前，科威尔技术股份有限公司（以下简称"公司"）职工董事徐文女士直接持有公司股 份13,000股，占公司总股本比例为0.0155%，股份来源为股权激励取得，均为无限售条件流通股。 ● 减持计划的实施结果情况 公司于2025年10月22日披露了《董事股份减持计划公告》，公司职工董事徐文女士计划通过集中竞价交 易方式减持所持股份不超过3,250股，占公司总股本比例不超过0.0039%。 公司于近日收到徐文女士出具的《关于股份减持计划实施结果告知函》，截至2026年2月11日，本次减 持计划实施时间已届满，本次减持计划期间内，徐文女士未减持其所持有的公司股份。 （三）本次实际减持情况与此前披露的减持计划、承诺是否一致 √是 □否 （四）减持时间区间届满，是否未实施减持 √未实施 ...

根据《上市公司募集资金监管规则》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板 上市公司自律监管指引第1号一一规范运作》等相关法律法规、规章及其他规范性文件的规定，上述账 户仅用于部分闲置募集资金进行现金管理的专用结算，不得用于存放非募集资金或用作其他用途。 二、风险控制措施 证券代码：688348 证券简称：昱能科技 公告编号：2026-007 昱能科技股份有限公司 关于开立募集资金现金管理专用结算账户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 昱能科技股份有限公司（以下简称"公司"）于2025年6月16日召开第二届董事会第十八次会议、第二届 监事会第十五次会议，审议通过了《关于使用部分暂时闲置募集资金进行现金管理的议案》，同意公司 在保证不影响募集资金投资项目实施、确保募集资金安全的前提下，使用最高不超过人民币12亿元 （含）的暂时闲置募集资金进行现金管理。使用期限自前次募集资金现金管理的授权到期之日起12个月 内有效，即2025年7月22日起至2026年7月21日。在使用授权期限内，资金可以循 ...

Core Viewpoint - Beijing Fuyuan Pharmaceutical Co., Ltd. has participated in the national organized procurement for expiring drug agreements and has several products expected to be selected for continued procurement, which is anticipated to positively impact the company's market share and future operating performance [1][2]. Group 1: Announcement of Selected Products - The company participated in the national organized procurement for expiring drug agreements on February 9, 2026, and has several key products expected to be selected for this procurement [1]. - The selected products include the top five in terms of revenue scale, with additional products such as Venlafaxine Hydrochloride Sustained-Release Capsules also participating [1]. - The procurement cycle for the selected products will run from the date of selection until December 31, 2028 [1]. Group 2: Impact of Selection on the Company - The expected selection of products is projected to stabilize the company's existing market share despite a decrease in sales prices [2]. - The company aims to leverage its brand influence and reliable supply capabilities to further increase its market share, which is expected to have a positive impact on future operating performance [2]. - The implementation of the procurement results is anticipated to begin by the end of March 2026, with provincial medical institutions signing procurement contracts based on the selection results [2].

证券代码：601188 证券简称：龙江交通 公告编号：临2026-008 黑龙江交通发展股份有限公司 关于审计机构变更项目合伙人及质量复核人的公告 上述项目合伙人、质量控制复核人近三年不存在因执业行为受到刑事处罚，不存在受到证监会及其派出 机构、行业主管部门的行政处罚、监督管理措施的情况，不存在受到证券交易所、行业协会等自律组织 的自律监管措施、纪律处分的情况。 中审亚太作为公司聘任的2025年度财务报表和内部控制的审计机构，原委派冯建江先生为项目合伙人、 马玉婧女士为独立复核人。鉴于中审亚太内部工作调整，现将项目合伙人变更为侯胜利先生、质量复核 人变更为董孟渊先生，签字注册会计师杜丽女士不变更。 二、本次变更人员的信息 1.基本信息 签字项目合伙人：侯胜利先生，2004年12月成为注册会计师，2017开始从事上市公司审计，2025年12月 开始在中审亚太执业，近三年签署或复核上市公司5家。 质量控制复核人：董孟渊先生，2004年6月成为注册会计师，2020年11月开始在中审亚太执业，2012年 开始从事上市公司和挂牌公司审计业务，2020年开始从事上市公司和挂牌公司质量控制复核工作；近三 年复核6家上市公司 ...

Core Viewpoint - The company plans to conduct currency and commodity derivatives hedging business in 2026 to mitigate foreign exchange and price volatility risks associated with its trading operations [4][44]. Group 1: Transaction Overview - The primary purpose of the currency derivatives hedging business is to hedge against foreign exchange risks arising from the company's import and export activities [4]. - The maximum contract value held on any trading day during the transaction period is expected to not exceed $2 billion or its equivalent in foreign currency [4]. - The funding for the hedging activities will come from the company's own funds or credit lines from financial institutions, without involving raised funds [4][45]. Group 2: Approval Process - The proposal for the currency derivatives hedging business has been approved by the company's third board meeting and the audit committee, pending approval from the shareholders' meeting [2][8]. Group 3: Risk Analysis and Control Measures - The company acknowledges various risks associated with the hedging activities, including market risk, funding risk, credit risk, internal control risk, and policy risk [3][9]. - To manage market risk, the company will monitor the valuation changes of hedged objects and derivatives, ensuring that hedging is based on actual business needs [15]. - The company will prioritize reputable financial institutions as trading partners to mitigate credit risk [17]. Group 4: Impact on the Company - The hedging activities are closely related to the company's daily operations and aim to improve its ability to manage foreign exchange and commodity price volatility risks [20][58]. - The accounting treatment for the hedging transactions will comply with relevant financial reporting standards, reflecting the appropriate items in the balance sheet and income statement [20][58].

Group 1 - The company held its sixth meeting of the ninth board of directors on February 11, 2026, with all nine directors present, confirming the meeting's legality and effectiveness [2][4]. - The board approved the proposal to expand the business scope and amend the company's articles of association, which will be submitted for review at the first extraordinary shareholders' meeting of 2026 [3][5]. - The board also approved the establishment of a remuneration management system for directors and senior management, aimed at enhancing management efficiency and aligning with national regulations [6][8]. Group 2 - The company plans to provide a guarantee of up to RMB 1.85 billion for its subsidiaries and associated companies in 2026, which is deemed manageable and beneficial for daily operations [9][10]. - The board's decision on the guarantee proposal will also be submitted for approval at the upcoming shareholders' meeting [11][12]. - The company has no overdue guarantees and the total amount of guarantees provided currently stands at RMB 1,095.44 million, representing 12.42% of the latest audited net assets [49][50]. Group 3 - The company aims to enhance its product offerings by adding new categories related to special equipment manufacturing and hydrogen energy, which aligns with market opportunities in the energy sector [16][18]. - The amendments to the articles of association will take effect upon approval by the shareholders' meeting [17][18]. - The first extraordinary shareholders' meeting of 2026 is scheduled for February 27, 2026, with a combination of on-site and online voting [20][22].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：601700 证券简称：风范股份公告编号：2026-019 常熟风范电力设备股份有限公司 关于控股股东部分股份质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: ● 常熟风范电力设备股份有限公司（以下简称"公司"）控股股东唐山工业控股集团有限公司（以下简 称"唐山工控"）持有公司股份342,559,785股，占公司总股本的29.99%。本次股份质押数量为24,125,000 股，占其所持公司股份的7.04%，本次股份质押后，其累计质押公司股份96,465,337股，占其所持公司 股份的28.16%，占公司目前总股本的8.45%。 公司于2026年2月11日接到公司控股股东唐山工控的通知，获悉其将持有的本公司部分股份办理了质押 手续，具体情况如下： 一、本次股东部分股份质押的基本情况 ■ 二、股东累计质押股份情况 四、备查文件 1、中国证券登记结算有限责任公司证券质押登记证明 2、质押合同 特此公告 截至公告披露日，上述股东及其一致行动人累 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次会议是否有否决议案：无 一、会议召开和出席情况 (一)股东会召开的时间：2026年2月11日 (二)股东会召开的地点：天津市北辰区高峰路与天宁道交口中材节能大厦11层第2会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： ■ (四)表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次会议由公司董事会召集，董事长孟庆林先生主持，采用现场记名投票与网络投票相结合的方式表 决。本次会议参与表决人数及召集、召开程序符合有关法律、行政法规和《公司章程》的有关规定。 (五)公司董事和董事会秘书的列席情况 1、公司在任董事8人，列席8人； 2、董事会秘书孟祥俊女士列席会议。 二、议案审议情况 (一)非累积投票议案 1、议案名称：《关于公司2026年度日常关联交易预计的议案》 审议结果：通过 表决情况： ■ 2、议案名称：《关于2024年度公司董事、监事薪酬分配方案的议案》 审议结果：通过 表决情况： ■ 3、议案名称：《关于公 ...

Core Viewpoint - The company, Guangdong Haomei New Materials Co., Ltd., has received an inquiry letter from the Shenzhen Stock Exchange regarding its application for a specific stock issuance, and it has responded to the inquiries and updated its application documents accordingly [1][2]. Group 1 - The company received the inquiry letter on January 25, 2026, from the Shenzhen Stock Exchange's Listing Review Center [1]. - The company, along with relevant intermediaries, conducted a thorough study of the questions raised in the inquiry letter and provided detailed responses [1]. - The updated content of the application documents, including the prospectus, was disclosed on February 12, 2026, on the Giant Tide Information Network [1]. Group 2 - The stock issuance is subject to approval by the Shenzhen Stock Exchange and registration consent from the China Securities Regulatory Commission, which introduces uncertainty regarding the approval timeline [2]. - The company will fulfill its information disclosure obligations based on the progress of these matters [2].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603669 证券简称：灵康药业（维权） 公告编号：2026-008 灵康药业集团股份有限公司 关于控股股东部分股份解除质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 公司控股股东灵康控股集团有限公司（以下简称"灵康控股"）直接及间接持有公司股份33,965.28万股 无限售流通股股票，占公司总股本的47.09%，灵康控股本次解除质押的股份4,965.96万股，占其持有公 司股份总数的14.62%，占公司总股本的6.89%。 2026年2月11日，灵康药业集团股份有限公司（以下简称"灵康药业"或"公司"）接到公司控股股东灵康 控股关于部分股份解除质押的通知，现将相关情况公告如下： ■ 经与灵康控股确认，解除质押的股份暂无后续质押计划。后续如有变动，公司将根据相关法律法规要求 及时履行信息披露义务。 特此公告。 灵康药业集团股份有限公司董事会 2026年2月12日 ...